 | • レポートコード：D0-MOR-AP0090 • 出版社/出版日：Mordor Intelligence / 2020年4月20日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：健康管理 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、アルボウイルス試験の世界市場について調査・分析した資料で、アルボウイルス試験の市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。 |
The Arbovirus Testing Market is expected to witness a CAGR of around 5.5%, during the forecast period (2020-2025).
The major factors accounting to the growth of the Arbovirus Testing Market are increasing rate of incidence and prevalence of Arbovirus throughout the world, recent advancements in technology and emerging rapid Serology Tests drives the Arbovirus Testing Market during the forecast period. For example, WHO has reported that the number of dengue cases reported increased over 15-fold over the last two decades, from 505,430 cases in 2000 to over 2,400,138 in 2010 and 3,312,040 in 2015. Deaths from 2000 to 2015 increased from 960 to more than 4032 which strongly supports the increase in the incidence of Arboviral diseases. Thus, the incidence rate of Arboviral diseases drives the growth of Arboviral Testing Market during the forecast period. However, lack of in vitro facilities, lack of awareness and limited availability of diagnostic testing procedures may restrain the market during the forecast period.
Key Market Trends
In Test Type Segment, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Tests Dominates the Market and the Same is Expected Over the Forecast Period.
RT-PCR based tests segement is expected to dominate the Arbovirus Testing Market over the forecast period attributing to its advantages. A key difference between ELISA (Enzyme-linked immunosorbant assay) and PCR tests is detection limit. Typically, an ELISA-based method will have a limit of 104-106 CFU/ml, whereas a PCR method can detect in the range of 103 CFU/ml. This difference in detection limit usually means that a longer enrichment time is required for an ELISA method. Even in terms of sensitivity, PCR technique is very sensitive and specific over ELISA. The wastes produced in the laboratories by adopting PCR technique is less compared to ELISA. Hence, all these factors together suggests that RT-PCR based tests dominates the Arboviral Testing market during the forecast period.
North America Dominates the Market and the Same is Expected Over the Forecast Period.
North America is expected to dominate the overall market, throughout the forecast period, which is attributed to the developed economy, increasing health care expenditure, and high adoption of technologically advanced products in the region. Thus, North America dominates the Arboviral Testing market during the forecast period. The market in Asia Pacific is expected to grow at high CAGR due to larger population density which facilitates the easy spread of Arboviral diseases.
Competitive Landscape
The Arbovirus Testing Market is moderately competitive and consists of several major players. With the increasing consolidations of various organizations and product recalls in the healthcare sector, it is expected to generate the competitive rivalry among the key players in future. Some of the major players of the market are Agilent Technologies, Inc., Thermo Fisher Scientific, NovaTec Immundiagnostica GmbH, Euroimmun AG, Abbott Laboratories etc.,
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in the Incidence and Prevalence of Arbovirus
4.2.2 Advancement in Technology
4.2.3 Rapid Serology Tests
4.3 Market Restraints
4.3.1 Lack of Invitro Facilities
4.3.2 Lack of Awareness and Limited Availability of Diagnostic Testing Procedures
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Test Type
5.1.1 ELISA-based Tests
5.1.2 RT-PCR based Tests
5.1.3 Others
5.2 By End-User
5.2.1 Diagnostic Laboratories
5.2.2 Hospitals
5.2.3 Research Centers
5.2.4 Others
5.3 By Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies, Inc.
6.1.2 Thermo Fisher Scientific
6.1.3 NovaTec Immundiagnostica GmbH
6.1.4 Euroimmun AG
6.1.5 Abbott Laboratories
6.1.6 DiaSorin S.p.A.
6.1.7 Bio-Rad
6.1.8 Fluke Biomedical
6.1.9 Copley Scientific
6.1.10 Distek
7 MARKET OPPORTUNITIES AND FUTURE TRENDS